AAAAAA

   
Results: 1-12 |
Results: 12
Genotypic correlates of a virologic response to stavudine after zidovudinemonotherapy
Authors: Shulman, NS Machekano, RA Shafer, RW Winters, MA Zolopa, AR Liou, SH Hughes, M Katzenstein, DA
Citation: Ns. Shulman et al., Genotypic correlates of a virologic response to stavudine after zidovudinemonotherapy, J ACQ IMM D, 27(4), 2001, pp. 377-380
Variants other than aspartic acid at codon 69 of the human immunodeficiency virus type 1 reverse transcriptase gene affect susceptibility to nucleoside analogs
Authors: Winters, MA Merigan, TC
Citation: Ma. Winters et Tc. Merigan, Variants other than aspartic acid at codon 69 of the human immunodeficiency virus type 1 reverse transcriptase gene affect susceptibility to nucleoside analogs, ANTIM AG CH, 45(8), 2001, pp. 2276-2279
Functional correlates of insertion mutations in the protease gene of humanimmunodeficiency virus type 1 isolates from patients
Authors: Kim, EY Winters, MA Kagan, RM Merigan, TC
Citation: Ey. Kim et al., Functional correlates of insertion mutations in the protease gene of humanimmunodeficiency virus type 1 isolates from patients, J VIROLOGY, 75(22), 2001, pp. 11227-11233
Frequency of antiretroviral drug resistance mutations in HIV-1 strains from patients failing triple drug regimens
Authors: Winters, MA Baxter, JD Mayers, DL Wentworth, DN Hoover, ML Neaton, JD Merigan, TC
Citation: Ma. Winters et al., Frequency of antiretroviral drug resistance mutations in HIV-1 strains from patients failing triple drug regimens, ANTIVIR TH, 5(1), 2000, pp. 57-63
A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy
Authors: Baxter, JD Mayers, DL Wentworth, DN Neaton, JD Hoover, ML Winters, MA Mannheimer, SB Thompson, MA Abrams, DI Brizz, BJ Ioannidis, JPA Merigan, TC
Citation: Jd. Baxter et al., A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy, AIDS, 14(9), 2000, pp. F83-F93
Reproducibility of human immunodeficiency virus type 1 (HIV-1) protease and reverse transcriptase sequencing of plasma samples from heavily treated HIV-1-infected individuals
Authors: Shafer, RW Warford, A Winters, MA Gonzales, MJ
Citation: Rw. Shafer et al., Reproducibility of human immunodeficiency virus type 1 (HIV-1) protease and reverse transcriptase sequencing of plasma samples from heavily treated HIV-1-infected individuals, J VIROL MET, 86(2), 2000, pp. 143-153
Genotypic, phenotypic, and modeling studies of a deletion in the beta 3-beta 4 region of the human immunodeficiency virus type 1 reverse transcriptase gene that is associated with resistance to nucleoside reverse transcriptase inhibitors
Authors: Winters, MA Coolley, KL Cheng, P Girard, YA Hamdan, H Kovari, LC Merigan, TC
Citation: Ma. Winters et al., Genotypic, phenotypic, and modeling studies of a deletion in the beta 3-beta 4 region of the human immunodeficiency virus type 1 reverse transcriptase gene that is associated with resistance to nucleoside reverse transcriptase inhibitors, J VIROLOGY, 74(22), 2000, pp. 10707-10713
Clinical cross-resistance between the HIV-1 protease inhibitors saquinavirand indinavir and correlations with genotypic mutations
Authors: Schapiro, JM Winters, MA Lawrence, J Merigan, TC
Citation: Jm. Schapiro et al., Clinical cross-resistance between the HIV-1 protease inhibitors saquinavirand indinavir and correlations with genotypic mutations, AIDS, 13(3), 1999, pp. 359-365
Resistance mutations to zidovudine and saquinavir in patients receiving zidovudine plus saquinavir or zidovudine and zalcitabine plus saquinavir in AIDS Clinical Trials Group 229
Authors: Schapiro, JM Lawrence, J Speck, R Winters, MA Efron, B Coombs, RW Collier, AC Merigan, TC
Citation: Jm. Schapiro et al., Resistance mutations to zidovudine and saquinavir in patients receiving zidovudine plus saquinavir or zidovudine and zalcitabine plus saquinavir in AIDS Clinical Trials Group 229, J INFEC DIS, 179(1), 1999, pp. 249-253
Frequency of class I HLA-restricted anti-HIV CD8(+) T cells in individualsreceiving highly active antiretroviral therapy (HAART)
Authors: Gray, CM Lawrence, J Schapiro, JM Altman, JD Winters, MA Crompton, M Loi, M Kundu, SK Davis, MM Merigan, TC
Citation: Cm. Gray et al., Frequency of class I HLA-restricted anti-HIV CD8(+) T cells in individualsreceiving highly active antiretroviral therapy (HAART), J IMMUNOL, 162(3), 1999, pp. 1780-1788
Protein purification with vapor-phase carbon dioxide
Authors: Winters, MA Frankel, DZ Debenedetti, PG Carey, J Devaney, M Przybycien, TM
Citation: Ma. Winters et al., Protein purification with vapor-phase carbon dioxide, BIOTECH BIO, 62(3), 1999, pp. 247-258
Multiple concurrent reverse transcriptase and protease mutations and multidrug resistance of HIV-1 isolates from heavily treated patients (vol 128, pg 906, 1998)
Authors: Shafer, RW Winters, MA Palmer, S Merigan, TC
Citation: Rw. Shafer et al., Multiple concurrent reverse transcriptase and protease mutations and multidrug resistance of HIV-1 isolates from heavily treated patients (vol 128, pg 906, 1998), ANN INT MED, 129(12), 1998, pp. 1083-1083
Risultati: 1-12 |